Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy

Diabetic Medicine

Volumn 19, Issue 8, 2002, Pages 655-660

  Hernandez C ^a   Lecube, A ^a   Segura, R M ^a   Sararols, L ^a   Simo R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Diabetic retinopathy; Nitric oxide; Vascular endothelial growth factor; Vitreous fluid

Indexed keywords

NITRIC OXIDE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIFFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE SURGERY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; VITREOUS BODY;

DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; NITRIC OXIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VITREOUS BODY;

EID: 0036360855     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00768.x     Document Type: Article

References (33)

1. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P
2. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism
3. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature
4. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
5. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
6. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
7. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
8. Biochemistry of nitric oxide and its redox-activated forms
9. Nitrite and nitrate determinations in plasma: A critical evaluation
10. Determination of nitrite/nitrate in human biological material by the simple Griess reaction
11. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
12. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase
13. A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry
14. Methods for measuring plasma hemoglobin in micromolar conentration compared
15. Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma
16. Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retina pigmented epithelial cells
17. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta
18. Human retina pigment epithelial cells produce nitric oxide in response to cytokines
19. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy
20. Inducible nitric oxide synthase: What difference does it make?
21. Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization
22. Nitric oxide synthase expression, enzyme activity and NO production during angiogenesis in the chick chorioallantoic membrane
23. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products
24. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy
25. The splice variants of vascular endothelial growth factor (VEGF) and their receptors
26. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells
27. VEGF-induced permeability increase is mediated by caveolae
28. Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: The role of NO
29. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF
30. Suppression of hypoxia-associated vascular endothelial growth factor gene expression by nitric oxide via cGMP
31. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway
32. Angiogenesis in cancer, vascular, rheumatoid and other disease
33. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide